The global in-vitro fertilization microscope market size is anticipated to reach USD 193.25 million by 2030 and it is projected to grow at a CAGR of 8.45% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing availability of financial assistance and the improving success rates of in-vitro fertilization (IVF) procedures are factors contributing to the market growth. Improving the success rate of IVF and achieving more successful pregnancies with fewer embryo transfers is a top priority for experts.
The growing adoption of AI and Machine Learning (ML) has enabled healthy sperm selection, increasing the efficiency of the IVF process. For instance, in March 2019, Olympus Corporation and Jikei University School of Medicine collaborated to develop an AI-assisted sperm selection process to reduce the overall time required for the Intracytoplasmic Sperm Injection (ICSI) procedure. This shift is anticipated to substantially improve the success rates of IVF procedures and reduce the need for invasive testing.
Government initiative acknowledges the importance of reproductive health and aims to empower women in making choices regarding family planning. For instance, in January 2022, Madrid was set to introduce a new fertility plan to promote IVF treatment for women in the region. Under this plan, women under the age of 45 will have access to IVF treatment through the public health system. The initiative reflects the authorities' efforts to encourage more women to pursue motherhood and address the declining birth rate. Such initiatives are expected to increase the demand for IVF treatment, thus driving the IVF microscope market.
Based on the end-use, the clinical segment led the market in 2023 with the largest revenue share of 94%, owing to increasing awareness about IVF treatment and growing private investments in infertility clinics
The clinical segment is also expected to register the fastest CAGR over the forecast period
Europe dominated the in-vitro fertilization microscope market owing to factors such as favorable legal reforms, rapid product innovations, and the growing scope of fertility tourism
In October 2023, Hamilton Thorne Ltd. acquired Gynetics Services B.V and Gynetics Medical Products, N.V., expanding its expertise, manufacturing capabilities, and product offerings in consumables, mainly in the European IVF market. Gynetics Medical Products, N.V. and Gynetics Services B.V. manufacture IVF devices
Please note The report will be delivered in 2-3 business days upon order notification.
Chapter 1. In-vitro Fertilization Microscope Market: Methodology and Scope